Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 410 participants.

Also called NCT06767345

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 410 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06767345
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06767345. Randomized; no masking; primary purpose treatment. Start 2025-05-12 (actual); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Condition
Atherosclerosis of Coronary Artery
Condition
Plaque, Atherosclerotic
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Rosuvastatin/ezetimibe
Lead sponsor
Korea University Anam Hospital (class: other)
Collaborator
Yuhan Corporation (class: industry)
Collaborator
Hanmi Pharmaceutical co., ltd. (class: other)

Record details

Record id
cardio:ct-nct06767345
Content hash
c7446cbacd02401d797a6ac95758fd26c093a7f908d22da638f0707ffd5d56e7